ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd (603976) - Net Assets
Based on the latest financial reports, ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd (603976) has net assets worth CN¥1.21 Billion CNY (≈ $177.36 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.95 Billion ≈ $284.93 Million USD) and total liabilities (CN¥735.16 Million ≈ $107.58 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 603976 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.21 Billion |
| % of Total Assets | 62.24% |
| Annual Growth Rate | 9.6% |
| 5-Year Change | 3.36% |
| 10-Year Change | 133.99% |
| Growth Volatility | 22.69 |
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd - Net Assets Trend (2013–2025)
This chart illustrates how ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd's net assets have evolved over time, based on quarterly financial data. See 603976 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd (2013–2025)
The table below shows the annual net assets of ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd from 2013 to 2025. For live valuation and market cap data, see 603976 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.21 Billion ≈ $176.36 Million |
-1.49% |
| 2024-12-31 | CN¥1.22 Billion ≈ $179.02 Million |
+0.65% |
| 2023-12-31 | CN¥1.22 Billion ≈ $177.87 Million |
+2.64% |
| 2022-12-31 | CN¥1.18 Billion ≈ $173.29 Million |
+1.56% |
| 2021-12-31 | CN¥1.17 Billion ≈ $170.62 Million |
+12.07% |
| 2020-12-31 | CN¥1.04 Billion ≈ $152.24 Million |
+0.43% |
| 2019-12-31 | CN¥1.04 Billion ≈ $151.60 Million |
+4.96% |
| 2018-12-31 | CN¥987.02 Million ≈ $144.43 Million |
+3.47% |
| 2017-12-31 | CN¥953.93 Million ≈ $139.59 Million |
+85.21% |
| 2016-12-31 | CN¥515.05 Million ≈ $75.37 Million |
+11.79% |
| 2015-12-31 | CN¥460.74 Million ≈ $67.42 Million |
+4.70% |
| 2014-12-31 | CN¥440.04 Million ≈ $64.39 Million |
+9.70% |
| 2013-12-31 | CN¥401.13 Million ≈ $58.70 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 809.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥418.03 Million | 34.69% |
| Other Components | CN¥787.16 Million | 65.31% |
| Total Equity | CN¥1.21 Billion | 100.00% |
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd Competitors by Market Cap
The table below lists competitors of ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tilray Inc
NASDAQ:TLRY
|
$565.73 Million |
|
Beijing Jingcheng Machinery Electric Co Ltd
SHG:600860
|
$565.76 Million |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
$565.97 Million |
|
Ulusoy Elektrik Imalat
IS:ULUSE
|
$566.21 Million |
|
Idaho Strategic Resources Inc
NYSE MKT:IDR
|
$565.54 Million |
|
Phreesia Inc
NYSE:PHR
|
$565.49 Million |
|
Krispy Kreme Inc
NASDAQ:DNUT
|
$565.47 Million |
|
Continental Holdings Corp
TW:3703
|
$565.40 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,223,406,926 to 1,205,182,597, a change of -18,224,329 (-1.5%).
- Net income of 18,903,770 contributed positively to equity growth.
- Dividend payments of 44,483,953 reduced retained earnings.
- Other comprehensive income decreased equity by 80,044,238.
- Other factors increased equity by 87,400,093.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥18.90 Million | +1.57% |
| Dividends Paid | CN¥44.48 Million | -3.69% |
| Other Comprehensive Income | CN¥-80.04 Million | -6.64% |
| Other Changes | CN¥87.40 Million | +7.25% |
| Total Change | CN¥- | -1.49% |
Book Value vs Market Value Analysis
This analysis compares ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.21x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 7.18x to 3.21x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥3.56 | CN¥25.56 | x |
| 2014-12-31 | CN¥3.88 | CN¥25.56 | x |
| 2015-12-31 | CN¥4.06 | CN¥25.56 | x |
| 2016-12-31 | CN¥4.54 | CN¥25.56 | x |
| 2017-12-31 | CN¥7.55 | CN¥25.56 | x |
| 2018-12-31 | CN¥6.56 | CN¥25.56 | x |
| 2019-12-31 | CN¥6.79 | CN¥25.56 | x |
| 2020-12-31 | CN¥6.86 | CN¥25.56 | x |
| 2021-12-31 | CN¥7.77 | CN¥25.56 | x |
| 2022-12-31 | CN¥7.86 | CN¥25.56 | x |
| 2023-12-31 | CN¥8.15 | CN¥25.56 | x |
| 2024-12-31 | CN¥8.04 | CN¥25.56 | x |
| 2025-12-31 | CN¥7.97 | CN¥25.56 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.57%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.85%
- • Asset Turnover: 0.35x
- • Equity Multiplier: 1.58x
- Recent ROE (1.57%) is below the historical average (8.31%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 13.65% | 13.49% | 0.91x | 1.11x | CN¥14.63 Million |
| 2014 | 15.66% | 15.80% | 0.88x | 1.12x | CN¥24.91 Million |
| 2015 | 13.17% | 12.65% | 0.89x | 1.16x | CN¥14.62 Million |
| 2016 | 13.69% | 15.00% | 0.76x | 1.21x | CN¥19.01 Million |
| 2017 | 8.61% | 16.16% | 0.48x | 1.11x | CN¥-13.21 Million |
| 2018 | 8.39% | 13.89% | 0.53x | 1.14x | CN¥-15.94 Million |
| 2019 | 5.89% | 11.72% | 0.42x | 1.20x | CN¥-42.54 Million |
| 2020 | 5.10% | 10.57% | 0.38x | 1.27x | CN¥-50.99 Million |
| 2021 | 9.14% | 13.38% | 0.41x | 1.68x | CN¥-9.99 Million |
| 2022 | 5.47% | 8.13% | 0.40x | 1.70x | CN¥-53.65 Million |
| 2023 | 3.31% | 4.47% | 0.44x | 1.68x | CN¥-81.28 Million |
| 2024 | 4.35% | 6.65% | 0.41x | 1.60x | CN¥-69.09 Million |
| 2025 | 1.57% | 2.85% | 0.35x | 1.58x | CN¥-101.61 Million |
Industry Comparison
This section compares ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd's net assets metrics with peer companies in the Packaging & Containers industry.
Industry Context
- Industry: Packaging & Containers
- Average net assets among peers: $1,778,545,477
- Average return on equity (ROE) among peers: 11.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd (603976) | CN¥1.21 Billion | 13.65% | 0.61x | $565.54 Million |
| Zhuhai Zhongfu Enterprise Co Ltd (000659) | $2.55 Billion | 4.08% | 1.23x | $662.25 Million |
| Huangshan Novel Co Ltd (002014) | $2.52 Billion | 17.36% | 0.71x | $924.95 Million |
| Shenzhen Jinjia Color Printing Group Co Ltd (002191) | $582.75 Million | 26.43% | 1.49x | $854.01 Million |
| Xiamen Hexing Packaging Printing Co Ltd (002228) | $3.02 Billion | 7.71% | 1.32x | $559.30 Million |
| Shenzhen Beauty Star Co Ltd (002243) | $711.12 Million | 14.45% | 0.60x | $1.25 Billion |
| Zhejiang Great Southeast Co Ltd (002263) | $942.33 Million | 5.01% | 0.84x | $1.15 Billion |
| Shenzhen MYS Environmental Protection & Technology Co Ltd (002303) | $5.25 Billion | 10.20% | 0.39x | $817.89 Million |
| Shandong Lipeng Co Ltd (002374) | $80.52 Million | 16.87% | 1.96x | $501.81 Million |
| Zhejiang Zhongcheng Packing Material Co Ltd (002522) | $84.37 Million | 18.38% | 2.04x | $930.46 Million |
| Shanghai Luxin Packing Materials Science&Technology Co Ltd (002565) | $2.04 Billion | -2.94% | 0.43x | $2.01 Billion |
About ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd engages in the research and development, manufacturing, and selling of pharmaceutical glass packaging materials in China and internationally. It offers neutral borosilicate glass ampoule and tube injection bottles, low borosilicate tubular vial and ampoule bottles, oral liquid vials, and screw neck vials. The company also provides aluminum cap… Read more